Augmeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,446,455 | 1,108,364 | 1,139,231 | 1,728,945 | 2,330,324 | 1,724,878 | 1,737,653 | 1,303,631 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 127,163 | 47,375 | 72,419 | 157,259 | 195,223 | 51,933 | 8,245 | 13,089 |
| Equity | 209,701 | 257,076 | 329,495 | 486,754 | 681,977 | 733,909 | 742,156 | 755,244 |
| Liabilities | 116,903 | 49,030 | 53,071 | 47,074 | 105,622 | 52,189 | 67,306 | 41,466 |
| Non-current assets | 121,896 | 112,844 | 120,581 | 185,133 | 184,223 | 188,924 | 161,849 | 177,427 |
| Current assets | 203,664 | 192,445 | 261,448 | 347,696 | 602,366 | 595,866 | 646,466 | 618,280 |
| Total assets | 325,560 | 305,289 | 382,029 | 532,829 | 786,589 | 784,790 | 808,315 | 795,707 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 166,593 | 140,002 | 109,307 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +81.1% | -23.4% | +2.8% | +51.8% | +34.8% | -26.0% | +0.7% | -25.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 39.1% | 15.5% | 19.0% | 29.5% | 24.8% | 6.6% | 1.0% | 1.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 60.6% | 18.4% | 22.0% | 32.3% | 28.6% | 7.1% | 1.1% | 1.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.8% | 4.3% | 6.4% | 9.1% | 8.4% | 3.0% | 0.5% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 495,922 | 359,473 | 379,744 | 576,315 | 755,789 | 574,959 | 579,218 | 446,954 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Augmeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-08-23 | 2022-08-28 | 3.76 |
| 2022-07-25 | 2022-08-02 | 3.76 |
| 2022-05-17 | 2022-05-25 | 1254.58 |
Augmeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-02 | 2026-03-02 | 451.88 |
| 2026-01-08 | 2026-01-09 | 0.45 |
| 2026-01-05 | 2026-01-07 | 0.36 |
| 2026-01-01 | 2026-01-04 | 353.18 |
| 2025-11-07 | 2025-11-09 | 4801.17 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Augmeda, UAB (code 303256940) is a Private Limited Liability Company operating in logging. In 2025, it generated revenue of €1.30M and net profit of €13.1K, corresponding to a 1.0% profit margin. Revenue declined by 25.0% year on year and was 24.4% below the 2023 level, when turnover was €1.72M and profit €51.9K. Profit also weakened in 2024 to €8.2K before improving modestly in 2025. The balance sheet remained conservative: total assets stood at €795.7K, equity at €755.2K and liabilities at €41.5K, giving an equity ratio of 94.9% and debt-to-equity of 0.05. Asset turnover was 1.64x, while ROE was 1.7% and ROA 1.6%. Long-term assets were €177.4K and short-term assets €618.3K. Revenue per employee reached €651.8K and profit per employee €6.5K, indicating relatively high productivity despite the weaker 2025 revenue base.